Table. COVID-19 Vaccines Available for Use Worldwide
Vaccine Manufacturer Type Dosing Country in Authorized by Which Countries/Authorities Schedule Which Developed Comirnaty Pfizer/ mRNA 2 doses, 21 USA Approved in Bahrain, Brazil, New Zealand, Saudi Arabia, Switzerland Tozinameran BioNTech days apart Emergency Use Listing: WHO, Caribbean Regulatory System mRNA-BNT Emergency Use Authorization: Argentina, Australia, Bangladesh, 162b2 Bermuda, Botswana, Brunei, Cabo Verde, Canada, Chile, Colombia, Costa Rica, Ecuador, European Union, French Polynesia, Greenland, Guatemala, Hong Kong, Iceland, Indonesia, Iraq, Israel, Japan, Jordan, Kuwait, Lebanon, Libya, Liechtenstein, Malaysia, Maldives, Mexico, Moldova, Monaco, Mongolia, New Caledonia, Nigeria, Norway, North Macedonia, Oman, Pakistan, Panama, Peru, Philippines, Qatar, Saint Vincent and the Grenadines, Serbia, Singapore, Sri Lanka, South Africa, South Korea, St. Maarten, Thailand, Tunisia, Turkey, Ukraine, United Arab, Emirates, United Kingdom, USA, Uruguay, Vietnam Spikevax Moderna mRNA 2 doses, 28 USA Approved: Switzerland MRNA-1273 days apart Emergency Use Listing: WHO Emergency Use Authorization: Bangladesh, Botswana, Brunei, Canada, Columbia, European Union, Greenland, Guatemala, Honduras, Iceland, India, Indonesia, Israel, Japan, Kuwait, Libya, Maldives, Moldova, Mongolia, Nigeria, Norway, Philippines, Qatar, Saint Vincent and the Grenadines, Saudi Arabia, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, United Arab Emirates, United Kingdom, USA, Vietnam Vaxzevria AstraZeneca/ Adenovirus 2 doses, 28 United Approved: Brazil Covishield University of days apart; 2 Kingdom Emergency Use Listing: WHO, Africa Regulatory Taskforce, Caribbean AZD1222 Oxford doses, 4-12 Regulatory System Serum Institute weeks apart in Emergency Use Authorization: Algeria, Angola, Antigua, Argentina, of India under the UK or EU Australia, Bahamas, Bahrain, Bangladesh, Barbados, Bhutan, license Botswana, Brazil, Brunei, Cabo Verde, Cambodia, Canada, Chile, Colombia, Costa Rica, Côte d’Ivoire, Cyprus, Dominican Republic, Ecuador, Egypt, El Salvador, Eswatini, Ethiopia, European Union, Fiji, Georgia, Ghana, Greenland, Guatemala, Haiti, Honduras, Hungary, Iceland, India, Indonesia, Iran, Iraq, Jamaica, Japan, Kenya, Kiribati, Kuwait, Lebanon, Libya, Liechtenstein, Malaysia, Maldives, Mexico, Moldova, Mongolia, Morocco, Namibia, Nauru, Nepal, Nigeria, North Macedonia, Norway, Pakistan, Panama, Papua New Guinea, Peru, Philippines, Rwanda, Saint Vincent and the Grenadines, Saudi Arabia, Serbia, Seychelles, Sierra Leone, Solomon Islands, South Africa, South Korea, Sri Lanka, St. Kitts and Nevis, Sudan, Taiwan, Tajikistan, Thailand, Timor-Leste, Tonga, Tuvalu, Uganda, Ukraine, United Kingdom, Vanuatu, Vietnam, Zambia Emergency Authorization Withdrawn: Denmark, Norway JNJ-78436735 Johnson & Adenovirus 1 dose USA Emergency Use Listing: WHO, Africa Regulatory Taskforce Ad26.COV2.S Johnson/ Emergency Use Authorized: Australia, Bahrain, Bangladesh, Botswana, Janssen Brazil, Canada, Chile, Colombia, European Union, Ghana, Greenland, Iceland, Kuwait, Libya, Liechtenstein, Malaysia, Maldives, Mexico, Moldova, New Zealand, Nigeria, Norway, Philippines, Saint Vincent and the Grenadines, South Africa, South Korea, Switzerland, Thailand, Tunisia, Ukraine, United Kingdom, USA, Vietnam, Zambia Emergency Authorization Withdrawn: Denmark, Finland Sputnik V, Gam- Gamaleya Adenovirus 2 doses, given Russia Emergency Use Authorization: Albania, Algeria, Angola, Antigua and Covid-Vac Research 21 days apart* Barbuda, Argentina, Armenia, Azerbaijan, Bahrain, Bangladesh, Institute Belarus, Bolivia, Bosnian Serb Republic, Cameroon, Congo Republic, Djibouti, Ecuador, Egypt, Honduras, Gabon, Ghana, Guatemala, Guinea, Guyana, Hungary, India, Iran, Iraq, Jordan, Kazakhstan, Kenya, Kyrgyzstan, Laos, Lebanon, Maldives, Mali, Mauritius, Mexico, Moldova, Mongolia, Montenegro, Morocco, Myanmar, Namibia, Nepal, Nicaragua, Nigeria, North Macedonia, Oman, Pakistan, Palestinian Authority, Panama, Paraguay, Philippines, Russia, San Marino, Serbia, Seychelles, Slovakia, Sri Lanka, St. Vincent and the Grenadines, Syria, Tunisia, Turkey, Turkmenistan, United Arab Emirates, Uzbekistan, Venezuela, Vietnam, Zimbabwe Sputnik Light Gamaleya Adenovirus 1 dose Russia Emergency Use Approval: Belarus, Congo Republic, Kazakhstan, Research Kyrgyzstan, Mauritius, Mongolia, Nicaragua, Palestinian Authority, Institute Russia, Venezuela
CoronaVac Sinovac Inactivated 2 doses, 14 China Approved: China PiCoVacc Biotech SARS-CoV-2 days apart Emergency Use Listing: WHO virus Emergency Use Authorization: Azerbaijan, Bangladesh, Botswana, Brazil, Cambodia, Chile, Colombia, Dominican Republic, Ecuador, Egypt, Hong Kong, Indonesia, Laos, Malaysia, Mexico, Moldova, Nepal, Oman, Pakistan, Panama, Philippines, South Africa, Sri Lanka, Thailand, Timor-Leste, Tunisia, Turkey, Ukraine, Uruguay, Zimbabwe Stopped Use In: Malaysia Convidecia CanSino Adenovirus 1 dose China Approved: China Ad5-nCoV Biologics/ Emergency Use Authorization: Argentina, Chile, Ecuador, Hungary, Institute of Malaysia, Mexico, Moldova, Pakistan Biology Academy of Military Medical Sciences COVAXIN Bharat Inactivated 2 doses, 28 India Emergency Use Authorization: Botswana, Brazil, Guatemala, Guyana, BBV152A, B, C Biotech/ Indian SARS-CoV-2 days apart India, Iran, Mauritius, Mexico, Nepal, Nicaragua, Paraguay, Council of virus Philippines, Zimbabwe Medical Research/ National Institute of Virology EpiVacCorona Bektop/ Vector Protein- 2 doses, 21 Russia Approved: Turkmenistan Aurora-CoV Institute based days apart Early Use: Russia
ZF2001 Anhui Zhifei Protein- 3 doses, 4 China Emergency Use Authorization: China, Uzbekistan Longcom/ based weeks apart Institute of Medical Biology at the Chinese Academy of Medical Sciences Soberana 2 Finlay Vaccine Protein- 2 doses, 28 Cuba Emergency Use Approval: Iran Pasteur Institute/ based days apart Pasteur Institute of Iran Abdala Center for Protein- 3 doses, 14 Cuba Emergency Use Approval: Cuba CIGB-66 Genetic based days apart Engineering and Biotechnology of Cuba MVC-COV1901 Medigen/Dyna Protein- 2 doses, 28 Taiwan Emergency Use Approval: Taiwan vax based days apart BBIBP-CorV Beijing Inactivated 2 doses, 3 China Approved: Bahrain, China, United Arab Emirates Institute of coronavirus weeks apart Emergency Use Listing: WHO Biological Emergency Use Authorization: Angola, Argentina, Bangladesh, Bolivia, Products/ Brunei, Cambodia, Cameroon, Comoros, Egypt, Gabon, Gambia, Sinopharm Guyana, Hungary, Indonesia, Iran, Iraq, Jordan, Kyrgyzstan, Laos, Lebanon, Malaysia, Maldives, Moldova, Mongolia, Montenegro, Morocco, Mozambique, Namibia, Nepal, Niger, North Macedonia, Pakistan, Peru, Philippines, Republic of the Congo, Senegal, Sierra Leone, Solomon Islands, Sri Lanka, Thailand, Tunisia, Vietnam, Venezuela, Zimbabwe Name yet to be Wuhan Inactivated 2 doses, 21 China Approved: China announced Institute of SARS-CoV-2 days apart Limited use: United Arab Emirates Biological virus Products/ Sinopharm QazVac Research Inactivated 2 doses, 21 Kazakhstan Early Use: Kazakhstan QazCovid-in Institute for SARS-CoV-2 days apart Biological virus Safety Problems KCONVAC Shenzhen Inactivated 2 doses, 28 China Emergency Use Approval: China Kangtai SARS-CoV-2 days apart Biological virus Products CoviVac Chumakov Inactivated 2 doses, 14 Russia Early Use: Russia Center of the SARS-CoV-2 days apart Russian virus Academy of Sciences COVIran Barekat Shifa Pharmed Inactivated 2 doses, 14 Iran Emergency Use Approval: Iran Industrial SARS-CoV-2 days apart Group virus *Sputnik V uses two different adenovirus vectors for each of two doses (first dose is Ad26, second dose is Ad5).